Association of angiotensin converting enzyme (ACE) gene I/D polymorphism and polycystic ovary syndrome (PCOS)

Gene

Volumn 489, Issue 2, 2011, Pages 86-88

  Bayram, Banu ^a   Kiliççi, Çetin ^b   Önlü, Harun ^a   Özkurt, Mete ^c   Erkasap, Nilüfer ^c   Yildirim, Engin ^c   Şahin, Fezan ^c  

^a MU ALPARSLAN UNIVERSITY   (Turkey)

^b Private Mus Sifa Hospital   (Turkey)

^c ESKISEHIR OSMANGAZI UNIVERSITY   (Turkey)

Author keywords

ACE gene I D polymorphism; Polycystic ovary syndrome

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; GENOMIC DNA; PRIMER DNA;

ADULT; AGAR GEL ELECTROPHORESIS; ARTICLE; CAMERA; CONTROLLED STUDY; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE DELETION; GENE FREQUENCY; GENE INSERTION; GENETIC ASSOCIATION; GENOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; OVARY POLYCYSTIC DISEASE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; TURKEY (REPUBLIC);

ADULT; ALLELES; FEMALE; GENE FREQUENCY; GENETIC MARKERS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; PEPTIDYL-DIPEPTIDASE A; POLYCYSTIC OVARY SYNDROME; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; TURKEY;

EID: 80054856054     PISSN: 03781119     EISSN: 18790038     Source Type: Journal    
DOI: 10.1016/j.gene.2011.08.012     Document Type: Article

References (23)

1. Bagos P.G. Plasminogen activator inhibitor-I 4G/5G and 5, 10-methylene-tetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome. Mol. Hum. Reprod. 2009, 15(1):19-26.
2. Bayram B., Sayin E., Güneş H.V., Deǧirmenci I., Türkoǧlu Z., Doganer F., Turgut Coşan D. DD genotype of ACE gene I/D polymorphism is associated in a Turkish study population with osteoarthritis. Mol. Biol. Rep. 2011, 38:1713-1716.
3. Celik O., Yesilada E., Hascalik S., Celik N., Sahin I., Keskin L., Ozerol E. Angitensin-converting enzyme gene polymorphism and risk of insulin resistance in PCOS. Reprod Biomed Online 2010, 20(4):492-498.
4. Choi S.W., Gu B.H., Ramakrishna S., Park J.M., Baek K.H. Association between a single nucleotide polymorphism in MTHFR gene and polycystic ovary syndrome. Eur. J. Obstet. Gynecol. Reprod. Biol. 2009, 145:85-88.
5. Glenn K.L., Du Z.Q., Eisenmann J.C., Rothschild M.F. An alternative method for genotyping of the ACE I/D polymorphism. Mol. Biol. Rep. 2009, 36(6):1305-1310.
6. Hong S., Yang H., Yoo M.C., In C., Yim S., Jin S., Choe B., Chung J. Angiotensin converting enzyme gene polymorphism in Korean patients with primary knee osteoarthritis. Exp. Mol. Med. 2003, 35(3):189-195.
7. Karabulut A., Turgut S., Turgut G. Angiotensin converting enzyme gene insertion/deletion polymorphism in patients with polycystic ovary syndrome. Gynecol. Endocrinol. 2010, 26(6):393-398.
8. Karadeniz M., Erdoǧan M., Berdeli A., Saygili F., Yilmaz C. 4G/5G Polymorphism of PAI-1 gene and in Turkish patients with polycystic ovary syndrome. J. Assist. Reprod. Genet. 2007, 24:412-418.
9. Kilicci C., Bayram B., Ozkurt M., Onlu H., Erkasap N., Mutlu F. Plasminogen activator inhibitor type-1 (PAI-1) gene 4G/5G polymorphism and polycystic ovary syndrome (PCOS). Genet. Test. Mol. Biomarkers 2011, 10.1089/gtmb.2010.0251.
10. Kritchevsky S.B., Nicklas B.J., Visser M., Simonsick E.M., Newman A.B., Harris T.B., Lange E.M., Penninx B.W., Goodpaster B.H., Satterfield S., Colbert L.H., Rubin S.M., Pahor M. Angiotensin-converting enzyme insertion/deletion genotype, exercise and physical decline. JAMA 2005, 294(6):691-698.
11. Orio F., Palomba S., Di Biase S., Colao A., Tauchmanova L., Savastano S., Labella D., Russo T., Zullo F., Lombardi G. Homocysteine levels and C677T polymorphism of methylenetetrahydrofolate reductase in women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab. 2003, 88(2):673-679.
12. Özenli Y., Haydardedeoǧlu B., Micozkadioǧlu I., Şimşek E., Bulgan E., Baǧiş T. Anxiety, depression and ways of coping skills by women with polycystic ovary syndrome. A controlled study. J. Turkish-German Gynecol Assoc. 2008, 9(4):190-194.
13. Palep-Singh M., Picton H.M., Yates Z.R., Barth J., Balen A.H. Polycystic ovary syndrome and the single nucleotide polymorphisms of methylenetetrahydrofolate reductase: a pilot observational study. Hum. Fertil. 2007, 10(1):33-41.
14. Radakovic B., Goldstajn M.S. MTHFR C 677T mutation and 4G/5G PAI-1 polymorphism in patient with polycystic ovarian syndrome. Coll. Antropol. 2007, 31(3):919-921.
15. Sabbagh A.S., Otrock Z.K., Mahfoud Z.R., Zaatari G.S., Mahfouz R.A. Angiotensin-converting enzyme gene polymorphism and allele frequencies in the Lebanese population: prevalence and review of the literature. Mol. Biol. Rep. 2007, 34(1):47-52.
16. Shehab D.K., Al-Jarallah K.F., Alawadhi A.M., Al-Herz A., Nahar I., Haider M.Z. Prevalence of angiotensin-converting enzyme gene insertion-deletion polymorphism in patients with primary knee osteoarthritis. Clin. Exp. Rheumatol. 2008, 26:305-310.
17. Sun J., Fan H., Che Y., Cao Y., Wu X., Sun H., Liang F., Yi L., Wang Y. Association between ACE gene I/D polymorphisms and hyperandrogenism in women with polycystic ovary syndrome (PCOS) and controls. BMC Med. Genet. 2009, 10:64.
18. Sun L., Lv H., Wei W., Zhang D., Guan Y. Angiotensin-converting enzyme D/I and plasminogen activator inhibitor-1 4G/5G gene polymorphisms are associated with increased risk of spontaneous abortions in polycystic ovarian syndrome. J. Endocrinol. Invest. 2010, 33(2):77-82.
19. Tarkun I., Çetinarslan B., Cantürk Z., Türemen E. The plasma homocysteine concentrations and relationship with insulin resistance in young women with polycystic ovary syndrome. Turk. J. Endocrinol. Metab. 2005, 1:23-28.
20. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polyccstic ovary syndrome (PCOS). Hum. Reprod. 2004, 19(1):41-47. The Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group.
21. Tsanadis G., Vartholomatos G., Korkontzelos I., Avgoustatos F., Kakomisos G., Sotiriadis A., Tatsioni A., Eleftheriou A., Lolis D. Polycystic ovarian syndrome and thrombophilia. Hum. Reprod. 2002, 17(2):314-319.
22. Turgut S., Akin F., Akcilar R., Ayada C., Turgut G. Angiotensin converting enzyme I/D, angiotensinogen M235T and AT1-R A/C1166 gene polymorphisms in patients with acromegaly. Mol. Biol. Rep. 2011, 38(1):569-576.
23. Unsal T., Konac E., Yesilkaya E., Yilmaz A., Bideci A., Onen H.I., Cinaz P., Menevse A. Genetic polymorphisms of FSHR, CYP17, CYP1A1, CAPN10, INSR, SERPINE1 genes in adolescent girls with polycystic ovary syndrome. J. Assist. Reprod. Genet. 2009, 26:205-216.